AR and neoplasm: A benefit has also been shown in a combination of AR targeting with radiotherapy in AR+ TNBC, where AR modulation was used not only as a targeted therapy but also as a radio-sensitizing drug, leading to an amplified response of the tumor to radiotherapy [67].